These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16002024)

  • 21. Drug treatment courts are popular but do they work and are they ethical and appropriate for Canada?
    Christie T; Anderson JF
    Health Law Can; 2003 May; 23(4):70-9. PubMed ID: 12845932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodological, ethical, and legal considerations in drug court research.
    DeMatteo D; Filone S; Laduke C
    Behav Sci Law; 2011; 29(6):806-20. PubMed ID: 21971950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes among drug court participants: does drug of choice matter?
    Shaffer DK; Hartman JL; Listwan SJ; Howell T; Latessa EJ
    Int J Offender Ther Comp Criminol; 2011 Feb; 55(1):155-74. PubMed ID: 20110426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and benefits of combining probation and substance abuse treatment.
    Alemi F; Taxman F; Baghi H; Vang J; Thanner M; Doyon V
    J Ment Health Policy Econ; 2006 Jun; 9(2):57-70. PubMed ID: 17007484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders.
    Godley MD; Godley SH; Dennis ML; Funk RR; Passetti LL
    Addiction; 2007 Jan; 102(1):81-93. PubMed ID: 17207126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting success and failure in juvenile drug treatment court: a meta-analytic review.
    Stein DM; Deberard S; Homan K
    J Subst Abuse Treat; 2013 Feb; 44(2):159-68. PubMed ID: 22980448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of diversion and aftercare strategies for adult drug-involved offenders: a summary and methodological review of the outcome literature.
    Harvey E; Shakeshaft A; Hetherington K; Sannibale C; Mattick RP
    Drug Alcohol Rev; 2007 Jul; 26(4):379-87. PubMed ID: 17564873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental health court outcomes: a comparison of re-arrest and re-arrest severity between mental health court and traditional court participants.
    Moore ME; Hiday VA
    Law Hum Behav; 2006 Dec; 30(6):659-74. PubMed ID: 17053948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Juvenile drug treatment courts in the United States: initial lessons learned and issues being addressed.
    Cooper CS
    Subst Use Misuse; 2002; 37(12-13):1689-722. PubMed ID: 12487239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regional disparities of the therapeutic injunctions of drug users].
    Simmat-Durand L
    Sante Publique; 2000 Sep; 12(3):405-18. PubMed ID: 11142199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of the Rio Hondo DUI court: a 2-year field experiment.
    MacDonald JM; Morral AR; Raymond B; Eibner C
    Eval Rev; 2007 Feb; 31(1):4-23. PubMed ID: 17259573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of the New South Wales adult drug court program.
    Shanahan M; Lancsar E; Haas M; Lind B; Weatherburn D; Chen S
    Eval Rev; 2004 Feb; 28(1):3-27. PubMed ID: 14750289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug courts: a primer for the family physician.
    Lessenger JE; Roper GF
    J Am Board Fam Pract; 2002; 15(4):298-303. PubMed ID: 12150463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental health among suburban drug court participants.
    Weitzel JA; Nochajski TH; Coffey SF; Farrell MG
    Am J Drug Alcohol Abuse; 2007; 33(3):475-81. PubMed ID: 17613975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulnerable populations: drug court program clients.
    Speck PM; Connor PD; Hartig MT; Cunningham PD; Fleming B
    Nurs Clin North Am; 2008 Sep; 43(3):477-89, x-xi. PubMed ID: 18674677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matching Judicial Supervision to Clients' Risk Status in Drug Court.
    Marlowe DB; Festinger DS; Lee PA; Dugosh KL; Benasutti KM
    Crime Delinq; 2006; 52(1):52-76. PubMed ID: 18174915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of a reentry modified therapeutic community for offenders with co-occurring disorders: crime outcomes.
    Sacks S; Chaple M; Sacks JY; McKendrick K; Cleland CM
    J Subst Abuse Treat; 2012 Apr; 42(3):247-59. PubMed ID: 21943810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.